By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today said that it has signed a co-marketing deal with UK pathology and molecular diagnostic lab Unilabs-IHS to provide Roche's cobas HPV test to women in the UK.

Unilabs will provide the test as a follow-up to traditional Pap cervical smears and, upon request, as a primary screen for cervical pre-cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.